Qube Research & Technologies (QRT) Portfolio holdings
AUM
$72B
This Quarter Return
-0.84%
1 Year Return
+7.86%
3 Year Return
+23.62%
5 Year Return
+38.38%
10 Year Return
–
AUM
$260M
AUM Growth
–
Cap. Flow
+$260M
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
50.21%
Holding
328
New
328
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
SPDR S&P MidCap 400 ETF Trust
MDY
|
$32.8M |
| 2 |
Materials Select Sector SPDR Fund
XLB
|
$18.6M |
| 3 |
Technology Select Sector SPDR Fund
XLK
|
$14.8M |
| 4 |
Industrial Select Sector SPDR Fund
XLI
|
$11.9M |
| 5 |
Consumer Discretionary Select Sector SPDR Fund
XLY
|
$10.8M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Financials | 17.14% |
| 2 | Healthcare | 9.32% |
| 3 | Industrials | 8.46% |
| 4 | Consumer Discretionary | 7.83% |
| 5 | Technology | 6.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
PPL Corp
PPL
$27.1B
| $260K | 0.1% |
+9,216
| New | +$260K |
|
127
PG&E
PCG
$33.9B
| $258K | 0.1% |
+5,873
| New | +$258K |
|
128
Nutrien
NTR
$27.5B
| $256K | 0.1% |
+5,420
| New | +$256K |
|
129
Chipotle Mexican Grill
CMG
$55.4B
| $253K | 0.1% |
+39,300
| New | +$253K |
|
130
Campbell Soup
CPB
$9.96B
| $252K | 0.1% |
+5,839
| New | +$252K |
|
131
Kimberly-Clark
KMB
$42.7B
| $252K | 0.1% |
+2,293
| New | +$252K |
|
132
AstraZeneca
AZN
$255B
| $251K | 0.1% |
+7,188
| New | +$251K |
|
|
NBL
133
DELISTED
Noble Energy, Inc.
NBL
| $251K | 0.1% |
+8,298
| New | +$251K |
|
134
Cousins Properties
CUZ
$4.94B
| $246K | 0.09% |
+7,096
| New | +$246K |
|
135
Moody's
MCO
$89.5B
| $243K | 0.09% |
+1,511
| New | +$243K |
|
136
United Airlines
UAL
$35.1B
| $239K | 0.09% |
+3,449
| New | +$239K |
|
137
Bristol-Myers Squibb
BMY
$96.8B
| $237K | 0.09% |
+3,760
| New | +$237K |
|
|
FTSI
138
DELISTED
FTS International, Inc. Common Stock
FTSI
| $237K | 0.09% |
+645
| New | +$237K |
|
139
Capital One
COF
$142B
| $236K | 0.09% |
+2,471
| New | +$236K |
|
140
Royal Caribbean
RCL
$97.1B
| $236K | 0.09% |
+2,007
| New | +$236K |
|
141
Everest Group
EG
$14.7B
| $233K | 0.09% |
+908
| New | +$233K |
|
142
Cboe Global Markets
CBOE
$24.6B
| $231K | 0.09% |
+2,031
| New | +$231K |
|
143
Humana
HUM
$37.4B
| $230K | 0.09% |
+858
| New | +$230K |
|
144
Amgen
AMGN
$153B
| $229K | 0.09% |
+1,345
| New | +$229K |
|
145
HP
HPQ
$26.8B
| $227K | 0.09% |
+10,357
| New | +$227K |
|
146
Molson Coors Class B
TAP
$9.85B
| $226K | 0.09% |
+3,008
| New | +$226K |
|
147
S&P Global
SPGI
$165B
| $224K | 0.09% |
+1,174
| New | +$224K |
|
148
Idexx Laboratories
IDXX
$50.5B
| $221K | 0.09% |
+1,156
| New | +$221K |
|
149
Vertex Pharmaceuticals
VRTX
$102B
| $221K | 0.09% |
+1,361
| New | +$221K |
|
150
Gartner
IT
$18.4B
| $218K | 0.08% |
+1,858
| New | +$218K |
|